期刊文献+

基于HTR-8/SVneo细胞的化瘀消癥方谱效研究 被引量:3

Spectrum-Effect Relation Study of Huayu Xiaozheng Decoction Based on HTR-8/SVneo Cells
原文传递
导出
摘要 目的均匀设计对化瘀消癥方进行不同配伍,通过谱效分析筛选有效物质群。方法运用U8(85)均匀设计表分组设计化瘀消癥方,以HTR-8/SVneo细胞生长抑制率为药效学指标,结合液质联用(HPLC-MS)指纹图谱技术,经多元回归分析,初步探讨化瘀消癥方的有效物质群。结果初步推断其有效物质群为丹参酸B、隐丹参酮、二氢丹参酮Ⅰ、芍药内酯苷、苦杏仁苷。结论均匀设计与谱效研究相结合,初步得出了化瘀消癥方的有效物质群。 Objective Uniform design was applied to investigate the compatibility rules of Huayu Xiaozheng decoction and screen the effective substance group with spectrum-effect relation analysis.Methods Taking uniform design U8(85)to investigate the Huayu Xiaozheng decoction,combined with HTR-8 cell proliferation rate as an index and HPLC-MS fingerprinting,using the multiple regression analysis to obtain the optimal combination,finally confirming the effective substance group of Huayu Xiaozheng decoction.Results Correlation analysis preliminary inferred that the effective substance group includes salvianic acid B,cryptotanshinone,dihydrotanshinoneⅠ,paeoniflorin and amygdalin.Conclusion Uniform design with spectrum-effect relation analysis preliminarily identified the effective substance group of Huayu Xiaozheng decoction.
作者 邢燕红 郜洁 侯雪楠 袁烁 孙建华 邓高丕 XING Yanhong;GAO Jie;HOU Xuenan;YUAN Shuo;SUN Jianhua;DENG Gaopi(First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China;Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China)
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2019年第11期1357-1361,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 广东省中医优势病种突破项目(粤中医函[2015]19号) 邓高丕广东省名中医传承工作室项目(粤中医办函[2019]5号) 广东省自然科学基金项目(2018A030313469)
关键词 化瘀消癥方 均匀设计 谱效分析 有效物质群 Huayu Xiaozheng decoction uniform design spectrum-effect analysis effective substance group
  • 相关文献

参考文献28

二级参考文献328

共引文献490

同被引文献29

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部